Atherosclerosis Research
Atherosclerosis is a disease of the arterial system that is characterized by the accumulation of fatty deposits within arterial walls, known as 'atherosclerotic plaques'.
Atherosclerosis Research Products Targets
- PI 3-kinase (22)
- HMG-CoA Reductase (8)
- Matrix Metalloprotease (16)
- LXR-like Receptor (6)
- Elastase (1)
- Cell Adhesion Molecule (21)
- Lipoxygenase (8)
- Leukotriene and Related Receptor (13)
- Others (7)
- Cytokine Receptor (4)
- Cyclooxygenase (24)
- IRAK (1)
- PPARγ (16)
- PPARδ (5)
- PPARα (7)
- Angiotensin-Converting Enzyme (8)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- NO donors and precursors (9)
- nNOS (5)
- iNOS (11)
- eNOS (1)
- Urotensin-II Receptor (8)
- Angiotensin AT2 Receptor (3)
- Angiotensin AT1 Receptor (9)
- SREBP (2)
- GPBA Receptor (3)
- Phospholipase (16)
- Prostanoid Receptor (24)
- Cytokine (15)
- Platelet-Activating Factor (PAF) Receptor (5)
Products for Atherosclerosis Research - Page 26
- Cat.No. Product Name Information/Activity
-
BCN2691
L-Arginine
L-Arginine is the nitrogen donor for synthesis of nitric oxide, a potent vasodilator that is deficient during times of sickle cell crisis.
-
BCC5004
Nicorandil
Nicorandil (SG-75) is potassium channel activator.
-
BCC5670
SIN-1 chloride
16142-27-1
-
BCC6712
SNAP
79032-48-7
-
BCC6714
SNOG
57564-91-7
-
BCC6950
Spermine NONOate
Slow NO releasing agent
-
BCC6746
L-Canavanine sulfate
L-Canavanine sulfate is a selective inhibitor of inducible NO synthase.
-
BCC2865
L-NAME hydrochloride
L-NAME hydrochloride inhibits NOS with an IC50 of 70 μM. L-NAME is a precursor to NOS inhibitor L-NOARG which has an IC50 value of 1.4 μM.
-
BCC5674
7-NINA
161467-34-1
-
BCC6713
7-Nitroindazole
2942-42-9
